← All stocks

Pacira BioSciences, Inc.

PCRX Net selling
CIK 0001396814 #2583 in the set updated 18 Sep 2026
Bought (120 mo)
$876.08K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$125.69M
$2.89M on a plan · $60.82M straight out of an exercise
Sold at will
$61.97M
152 of 313 sales
Net
−$124.81M
−$61.09M against sales at will

By person

36 insiders · 361 transactions
17.1×

Frank Lee holds 17.1 times base salary in stock. $15.35M of shares against $896.54K in salary for 2024.

Salary from the company's own proxy. The shares are what Frank Lee last reported holding, valued at $23.23, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Wicki Andreas
Director
$40.51M (20)
−$40.51M
2,393,165
6.00%
$55.59M
−21.3%
STACK DAVID M
CEO and Chairman
$31.79M (56) scheduled
−$31.79M
302,980
0.7601%
$7.04M
+437.6%
WILLIAMS KRISTEN
Chief Administrative Officer
$14.18M (41) scheduled
−$14.18M
167,062
0.4191%
$3.88M
+967.5%
REINHARDT MAX
President, Rest of World
$6.61M (17) scheduled
−$6.61M
29,225
0.0733%
$678.90K
+2,050%
PACE GARY W
Director
$412.97K (2)
$5.87M (6)
−$5.46M
22,127
0.0555%
$514.01K
−0.2%
RIKER LAUREN
Senior Vice President, Finance
$4.73M (48) scheduled
−$4.73M
62,284
0.1563%
$1.45M
+346.3%
LARANJEIRA CHARLES ANTHONY
Chief Technical Officer
$3.81M (12) scheduled
−$3.81M
41,752
0.1047%
$969.90K
+1,667%
WINSTON ROY
Chief Medical Officer
$91.25K (1)
$3.31M (19) scheduled
−$3.22M
52,440
0.1316%
$1.22M
+163.8%
Scibetta James S
President
$2.61M (5) scheduled
−$2.61M
25,118
0.0630%
$583.49K
−7.3%
MOLLOY ANTHONY
Chief Lgl & Compliance Officer
$2.36M (11) scheduled
−$2.36M
12,877
0.0323%
$299.13K
−20.5%
Scranton Richard
Chief Scientific Officer
$1.98M (6) scheduled
−$1.98M
16,061
0.0403%
$373.10K
+231.6%
Cross Shawn
Chief Financial Officer
$1.52M (7) scheduled
−$1.52M
105,341
0.2643%
$2.45M
Brege Laura
Director
$12.81K (1)
$1.20M (4) scheduled
−$1.19M
30,120
0.0756%
$699.69K
+1,111%
LONGENECKER JOHN P PHD
Director
$923.42K (3) scheduled
−$923.42K
18,823
0.0472%
$437.26K
+396.9%
HASTINGS PAUL J
Director
$800.68K (10) scheduled
−$800.68K
12,724
0.0319%
$295.58K
+297.0%
SLONIN JONATHAN
Chief Medical Officer
$628.00K (12) scheduled
−$628.00K
216,384
0.5428%
$5.03M
+537.0%
McLoughlin Dennis
Chief Customer Officer
$608.87K (7)
−$608.87K
38,115
0.0956%
$885.41K
+125.7%
Reinhart Charles A. III
Chief Financial Officer
$555.97K (7)
−$555.97K
51,867
0.1301%
$1.20M
Kronenfeld Mark A.
Director
$152.46K (4)
$555.60K (1) scheduled
−$403.14K
34,901
0.0876%
$810.75K
+686.4%
GAUGLER DARYL
Chief Operating Officer
$327.84K (8) scheduled
−$327.84K
115,443
0.2896%
$2.68M
+784.5%
Manning Donald C.
Chief Medical Officer
$306.82K (2)
−$306.82K
29,520
0.0741%
$685.75K
Froimson Mark
Director
$19.93K (2)
$123.31K (3)
−$103.39K
26,541
0.0666%
$616.55K
Lee Frank D.
Chief Executive Officer
$99.99K (1)
+$99.99K
660,831
1.66%
$15.35M
+48,354%
Ellis Ronald J. Jr.
Chief Strategy Officer
$87.44K (2)
−$87.44K
30,909
0.0775%
$718.02K
−6.9%
Jones James B
SVP & Chief Medical Officer
$68.17K (2)
−$68.17K
16,823
0.0422%
$390.80K
+53.8%
Ceesay Abraham
Director
$64.01K (1) scheduled
−$64.01K
9,039
0.0227%
$209.98K
BIGAL MARCELO
Director
$60.87K (2)
$116.27K (1)
−$55.40K
17,798
0.0446%
$413.45K
Braunstein Scott
Chief Operating Officer
$33.27K (1)
−$33.27K
20,982
0.0526%
$487.41K
+95.2%
YANG MICHAEL J.
Director
$25.80K (1)
+$25.80K
19,798
0.0497%
$459.91K
Weiland Robert J.
Chief Commercial Officer
$12.32K (1)
−$12.32K
5,088
0.0128%
$118.19K
+429.4%
Teehan Brendan
Chief Commercial Officer
100,934
0.2532%
$2.34M
CHRISTIE CHRISTOPHER
Director
23,059
0.0578%
$535.66K
Young Alethia
Director
17,798
0.0446%
$413.45K
Greenstreet Yvonne
Director
13,247
0.0332%
$307.73K
+279.8%
WINGER DENNIS L
Director
7,490
0.0188%
$173.99K
+22.1%
Hirawat Samit
Director
6,405
0.0161%
$148.79K
Insider
Date
Role
Action
Shares
Price
Amount
Cross Shawn
23 Apr 2026
Chief Financial Officer
Sold after exercise
12,941
$25.16
$325.60K
Cross Shawn
22 Apr 2026
Chief Financial Officer
Sold after exercise
1,500
$25.01
$37.52K
Cross Shawn
21 Apr 2026
Chief Financial Officer
Sold after exercise
2,845
$25.01
$71.15K
Cross Shawn
20 Apr 2026
Chief Financial Officer
Sold after exercise
7,714
$25.14
$193.93K
Cross Shawn
10 Dec 2025
Chief Financial Officer
Sold after exercise
9,104
$25.14
$228.87K
Cross Shawn
9 Dec 2025
Chief Financial Officer
Sold after exercise
15,896
$25.03
$397.88K
Kronenfeld Mark A.
8 Jun 2023
Director
Sold after exercise
15,000
$37.04
$555.60K
GAUGLER DARYL
31 May 2023
Chief Operating Officer
Sold after exercise
2,500
$39.08
$97.70K
HASTINGS PAUL J
15 May 2023
Director
Sold after exercise
7,000
$41.85
$292.95K
PACE GARY W
11 May 2023
Director
Sold after exercise
5,015
$41.78
$209.53K
Brege Laura
3 Apr 2023
Director
Sold after exercise
7,000
$40.72
$285.04K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
123
$63.69
$7.83K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
1,891
$62.48
$118.15K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
3,650
$61.59
$224.80K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
3,533
$60.55
$213.92K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
115
$63.40
$7.29K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
1,300
$62.43
$81.16K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
2,300
$61.59
$141.66K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
2,535
$60.55
$153.49K
WINSTON ROY
6 Jun 2022
Chief Medical Officer
Sold after exercise
2,099
$61.37
$128.82K
REINHARDT MAX
21 Apr 2022
President, Rest of World
Sold after exercise
9,824
$73.25
$719.65K
REINHARDT MAX
20 Apr 2022
President, Rest of World
Sold after exercise
9,764
$73.99
$722.44K
REINHARDT MAX
19 Apr 2022
President, Rest of World
Sold after exercise
9,321
$72.25
$673.44K
REINHARDT MAX
18 Apr 2022
President, Rest of World
Sold after exercise
8,941
$73.55
$657.61K
MOLLOY ANTHONY
6 Apr 2022
Chief Lgl & Compliance Officer
Sold after exercise
2,503
$77.94
$195.08K
MOLLOY ANTHONY
6 Apr 2022
Chief Lgl & Compliance Officer
Sold after exercise
3,937
$77.03
$303.27K
MOLLOY ANTHONY
6 Apr 2022
Chief Lgl & Compliance Officer
Sold after exercise
16,060
$76.03
$1.22M
WILLIAMS KRISTEN
21 Mar 2022
Chief Administrative Officer
Sold after exercise
7,253
$72.67
$527.08K
RIKER LAUREN
10 Mar 2022
Senior Vice President, Finance
Sold after exercise
900
$71.95
$64.76K
RIKER LAUREN
10 Mar 2022
Senior Vice President, Finance
Sold after exercise
8,400
$71.14
$597.58K
LONGENECKER JOHN P PHD
3 Mar 2022
Director
Sold after exercise
7,000
$71.74
$502.15K
PACE GARY W
1 Mar 2022
Director
Sold after exercise
1,359
$67.75
$92.07K
PACE GARY W
28 Feb 2022
Director
Sold after exercise
28,641
$66.83
$1.91M
WILLIAMS KRISTEN
25 Feb 2022
Chief Administrative Officer
Sold after exercise
2,000
$67.07
$134.14K
WILLIAMS KRISTEN
25 Feb 2022
Chief Administrative Officer
Sold after exercise
50
$65.00
$3.25K
WILLIAMS KRISTEN
16 Feb 2022
Chief Administrative Officer
Sold after exercise
10
$65.00
$650.00
WILLIAMS KRISTEN
10 Feb 2022
Chief Administrative Officer
Sold after exercise
800
$65.18
$52.14K
WILLIAMS KRISTEN
4 Feb 2022
Chief Administrative Officer
Sold after exercise
1,000
$65.18
$65.18K
WILLIAMS KRISTEN
21 Jan 2022
Chief Administrative Officer
Sold after exercise
200
$65.41
$13.08K
WILLIAMS KRISTEN
19 Jan 2022
Chief Administrative Officer
Sold after exercise
2,199
$65.51
$144.06K
RIKER LAUREN
18 Jan 2022
Senior Vice President, Finance
Sold after exercise
2,500
$64.97
$162.43K
WILLIAMS KRISTEN
18 Jan 2022
Chief Administrative Officer
Sold after exercise
400
$66.14
$26.46K
WILLIAMS KRISTEN
18 Jan 2022
Chief Administrative Officer
Sold after exercise
23,040
$65.24
$1.50M
RIKER LAUREN
29 Jul 2021
Vice President, Finance
Sold after exercise
90
$60.81
$5.47K
RIKER LAUREN
28 Jul 2021
Vice President, Finance
Sold after exercise
2,410
$60.85
$146.65K
STACK DAVID M
12 May 2021
CEO and Chairman
Sold after exercise
3,611
$62.41
$225.36K
STACK DAVID M
12 May 2021
CEO and Chairman
Sold after exercise
14,669
$62.08
$910.65K
STACK DAVID M
12 May 2021
CEO and Chairman
Sold after exercise
2,970
$60.76
$180.46K
STACK DAVID M
11 May 2021
CEO and Chairman
Sold after exercise
7,932
$61.19
$485.36K
STACK DAVID M
11 May 2021
CEO and Chairman
Sold after exercise
13,318
$60.78
$809.47K
WILLIAMS KRISTEN
13 Apr 2021
Chief Administrative Officer
Sold after exercise
7,030
$68.11
$478.81K
WILLIAMS KRISTEN
13 Apr 2021
Chief Administrative Officer
Sold after exercise
14,793
$66.40
$982.26K
WINSTON ROY
31 Mar 2021
Chief Clinical Officer
Sold after exercise
1,200
$72.12
$86.54K
WINSTON ROY
31 Mar 2021
Chief Clinical Officer
Sold after exercise
4,661
$71.09
$331.35K
WINSTON ROY
31 Mar 2021
Chief Clinical Officer
Sold after exercise
16,363
$70.36
$1.15M
RIKER LAUREN
17 Mar 2021
Vice President, Finance
Sold after exercise
2,000
$70.01
$140.02K
RIKER LAUREN
15 Mar 2021
Vice President, Finance
Sold after exercise
1,520
$73.28
$111.39K
HASTINGS PAUL J
5 Mar 2021
Director
Sold after exercise
3,000
$65.88
$197.64K
LONGENECKER JOHN P PHD
1 Mar 2021
Director
Sold after exercise
5,000
$72.26
$361.30K
STACK DAVID M
3 Feb 2021
CEO and Chairman
Sold after exercise
14,350
$71.42
$1.02M
STACK DAVID M
3 Feb 2021
CEO and Chairman
Sold after exercise
6,900
$70.78
$488.38K
STACK DAVID M
2 Feb 2021
CEO and Chairman
Sold after exercise
4,100
$70.20
$287.82K
STACK DAVID M
2 Feb 2021
CEO and Chairman
Sold after exercise
14,250
$69.38
$988.67K
STACK DAVID M
2 Feb 2021
CEO and Chairman
Sold after exercise
2,900
$68.41
$198.39K
Brege Laura
16 Nov 2020
Director
Sold after exercise
12,000
$65.95
$791.40K
REINHARDT MAX
13 Nov 2020
President
Sold after exercise
21,000
$63.51
$1.33M
REINHARDT MAX
13 Nov 2020
President
Sold after exercise
4,000
$62.67
$250.68K
RIKER LAUREN
13 Nov 2020
Vice President, Finance
Sold after exercise
3,000
$63.81
$191.43K
STACK DAVID M
16 Oct 2020
CEO and Chairman
Sold after exercise
30,000
$55.56
$1.67M
STACK DAVID M
15 Oct 2020
CEO and Chairman
Sold after exercise
30,000
$55.00
$1.65M
STACK DAVID M
14 Oct 2020
CEO and Chairman
Sold after exercise
30,000
$55.53
$1.67M
WILLIAMS KRISTEN
17 Sep 2020
Chief Administrative Officer
Sold after exercise
3,200
$60.22
$192.70K
WILLIAMS KRISTEN
17 Sep 2020
Chief Administrative Officer
Sold after exercise
24,671
$59.77
$1.47M
REINHARDT MAX
17 Sep 2020
President
Sold after exercise
2,888
$60.26
$174.03K
REINHARDT MAX
17 Sep 2020
President
Sold after exercise
22,532
$59.75
$1.35M
RIKER LAUREN
16 Sep 2020
Vice President, Finance
Sold after exercise
3,000
$60.34
$181.02K
WILLIAMS KRISTEN
16 Sep 2020
Chief Administrative Officer
Sold after exercise
21,244
$60.33
$1.28M
WILLIAMS KRISTEN
16 Sep 2020
Chief Administrative Officer
Sold after exercise
6,609
$59.54
$393.50K
WILLIAMS KRISTEN
15 Sep 2020
Chief Administrative Officer
Sold after exercise
13,231
$59.80
$791.21K
WILLIAMS KRISTEN
15 Sep 2020
Chief Administrative Officer
Sold after exercise
14,622
$59.01
$862.84K
RIKER LAUREN
11 Aug 2020
Vice President, Finance
Sold after exercise
8,180
$60.50
$494.89K
LARANJEIRA CHARLES ANTHONY
3 Aug 2020
SVP, Technical Operations
Sold after exercise
2,500
$52.68
$131.70K
LARANJEIRA CHARLES ANTHONY
29 Jun 2020
SVP, Technical Operations
Sold after exercise
1,778
$52.03
$92.51K
LARANJEIRA CHARLES ANTHONY
29 Jun 2020
SVP, Technical Operations
Sold after exercise
6,859
$51.77
$355.09K
LARANJEIRA CHARLES ANTHONY
29 Jun 2020
SVP, Technical Operations
Sold after exercise
51,464
$50.01
$2.57M
RIKER LAUREN
29 Jun 2020
Vice President, Finance
Sold after exercise
2,000
$50.34
$100.68K
RIKER LAUREN
29 Jun 2020
Vice President, Finance
Sold after exercise
2,000
$49.34
$98.68K
RIKER LAUREN
29 Jun 2020
Vice President, Finance
Sold after exercise
2,000
$48.72
$97.44K
RIKER LAUREN
21 May 2020
Vice President, Finance
Sold after exercise
2,000
$45.26
$90.52K
RIKER LAUREN
19 May 2020
Vice President, Finance
Sold after exercise
2,000
$42.81
$85.62K
RIKER LAUREN
10 Feb 2020
Vice President, Finance
Sold after exercise
1,000
$49.81
$49.81K
RIKER LAUREN
10 Feb 2020
Vice President, Finance
Sold after exercise
1,000
$48.81
$48.81K
Showing 250 of 361 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 403
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 31
Sales straight out of an exercise 130
Sales at will 152
Transactions with no price 0
Shares from compensation/vesting 4,062,187
Sales filed before the plan box existed 125
History held since 7 Oct 2016